71.20
71.20 (0%)
As of Apr 17, 2025
ILLUMINA, INC. [ILMN]
Source:
Company Overview
Illumina, Inc is a global leader in sequencing- and array-based solutions for genetic and genomic analysis. Our products and services serve customers in a wide range of markets, enabling the adoption of genomic solutions in research and clinical settings.
| Country | United States |
| Headquarters | san diego, california |
| Phone Number | 8582024500 |
| Industry | manufacturing |
| CEO | Jacob Thaysen |
| Website | www.illumina.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $4,372 |
| Operating Profit | $-833 |
| Net Income | $-1,223 |
| Net Cash | $79 |
Profit Ratios
| Gross Margin | $2,861 |
| Operating Margin | -19.1 |
| Profit as % of Revenues | -233.9% |
| Profit as % of Assets | -14.9% |
| Profit as % of Stockholder Equity | -51.5% |
Management Effectiveness
| Return on Equity | -51.5% |
| Return on Assets | -19.4% |
| Turnover Ratio | 53.3% |
| EBITA | $-833 |
Balance Sheet and Cash Flow Measures
| Total Assets | $6,303 |
| Total Liabilities | $3,930 |
| Operating Cash Flow | $837 |
| Investing Cash Flow | $-178 |
| Financing Cash Flow | $-570 |
